Insider · CIK 0001233253
Arnold C Hanish
Files at OMER (OMEROS CORP), DCOY (Salarius Pharmaceuticals, Inc.). First filing Nov 24, 2025, latest Jan 2, 2026.
Arnold C Hanish files SEC Form 4 as director at DCOY (Salarius Pharmaceuticals, Inc.), and also at OMER (OMEROS CORP). Since Nov 24, 2025, Arnold C Hanish has reported 1 open-market buy worth $3,741 and 1 open-market sell worth $17, the latest filed on Jan 2, 2026.
A track record needs three past buys with six months of prices behind them; Arnold C Hanish has 0, so none is measured yet.
The newest scored trade: sold $17 of DCOY on Dec 30, 2025, filed Jan 2, 2026, scored 15 (weak). In the last 12 months: 1 buy worth $3,741 and 1 sell worth $17.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DCOY: Salarius Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | DCOYsell Salarius Pharmaceuticals, Inc. | $17 27 shares | -1% | +2% from low-99% from high | |
| 33Weak | Salarius Pharmaceuticals, Inc. | $3,741 5,000 shares | first purchase | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +3,000 | $0.00 | $0 | 3,418 | 41 d ago |
| Jun 18, 2026 | OMER OMEROS CORP | AGrant or award Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jun 22, 2026 |
| Dec 30, 2025 | DCOY Salarius Pharmaceuticals, Inc. | SOpen-market sale Common Stockindirect: By Arnold C. Hanish Trust | -15 | $0.64 | $10 | 5,000 | Jan 2, 2026 |
| Dec 30, 2025 | DCOY Salarius Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -12 | $0.64 | $8 | 0 | Jan 2, 2026 |
| Nov 20, 2025 | DCOY Salarius Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: By Arnold C. Hanish Trust | +5,000 | $0.75 | $3,741 | 5,015 | Nov 24, 2025 |
| Jun 27, 2025 | OMER OMEROS CORP | AGrant or award Stock Option (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Jul 1, 2025 |
Questions about Arnold C Hanish
Answered from the filings on this page, as of the latest one.
Is Arnold C Hanish buying or selling?
In the last 12 months Arnold C Hanish reported 1 open-market buy worth $3,741 and 1 open-market sell worth $17 on SEC Form 4; the latest was sold $17 of DCOY on Dec 30, 2025. Grants, option exercises and tax withholding are not counted.
How did Arnold C Hanish's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arnold C Hanish has 0.
Where does Arnold C Hanish file Form 4?
Arnold C Hanish has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.); OMER (OMEROS CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.